Catalyst Funds Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,821
Closed -$959K – 717
2026
Q2
$959K Buy
+1,821
New +$1.02M 0.05% 300
2025
Q4
– Sell
-500
Closed -$319K – 451
2025
Q3
$319K Hold
500
– – 0.05% 319
2025
Q2
$268K Buy
+500
New +$239K 0.07% 274

Other funds holding IDXX

Catalyst Funds Management's IDXX Position: Q3 2026 in Review

Catalyst Funds Management sold out of Idexx Laboratories (IDXX) in Q3 2026, closing a stake of 1,821 shares — an estimated $959K sold.

Catalyst Funds Management first reported a position in IDXX in Q2 2025 and held it in 3 quarters. The position peaked at $959K in Q2 2026. 1,272 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Catalyst Funds Management reported no remaining Idexx Laboratories position as of Q3 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 1,821 Idexx Laboratories shares in Q3 2026, an estimated $959K.
  • Catalyst Funds Management first reported a position in Idexx Laboratories in Q2 2025 and held it in 3 quarters.
  • Catalyst Funds Management's Idexx Laboratories position peaked at $959K in Q2 2026.
  • 1,272 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Catalyst Funds Management's 13F filing for Q3 2026, filed 12 Nov 2026.